Hulme WJ. et al, (2023), Annals of internal medicine, 176, 685 - 693
Changes in medication safety indicators in England throughout the covid-19 pandemic using OpenSAFELY: population based, retrospective cohort study of 57 million patients using federated analytics
Fisher L. et al, (2023), BMJ Medicine, 2, e000392 - e000392
Data-Driven Identification of Unusual Prescribing Behavior: Analysis and Use of an Interactive Data Tool Using 6 Months of Primary Care Data From 6500 Practices in England.
Hopcroft LE. et al, (2023), JMIR Med Inform, 11
OpenSAFELY NHS Service Restoration Observatory 2: changes in primary care clinical activity in England during the COVID-19 pandemic.
Curtis HJ. et al, (2023), Br J Gen Pract
OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide, and methotrexate monitoring, and factors associated with change in monitoring rate
The OpenSAFELY Collaborative None. et al, (2023)
The impact of lidocaine plaster prescribing reduction strategies: a comparison of two national health services in Europe
Mattsson M. et al, (2023)
The impact of lidocaine plaster prescribing reduction strategies: A comparison of two national health services in Europe
Mattsson M. et al, (2023), British Journal of Clinical Pharmacology
The impact of the COVID-19 pandemic on Antipsychotic Prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: A federated analysis of 59 million patients’ primary care records in situ using OpenSAFELY
The OpenSAFELY Collaborative: None. et al, (2023)
Identifying Patterns of Clinical Interest in Clinicians' Treatment Preferences: Hypothesis-free Data Science Approach to Prioritizing Prescribing Outliers for Clinical Review.
MacKenna B. et al, (2022), JMIR Med Inform, 10
Recording of ’COVID-19 vaccine declined‘: a cohort study on 57.9 million National Health Service patients’ records in situ using OpenSAFELY, England, 8 December 2020 to 25 May 2021
Curtis HJ. et al, (2022), Eurosurveillance, 27
Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY.
Hulme WJ. et al, (2022), BMJ, 378
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records
Horne EMF. et al, (2022), BMJ (Clinical research ed.), 378